|
1. World Health Organisation (WHO). Global tuberculosis report. 2014. Available at: http://apps.who.int/ iris/bitstream/10665/137094/1/9789241564809_eng.pdf. Accessed 20 July 2016. 2. World Health Organisation (WHO). Global tuberculosis control 2009. Epidemiology, strategy, financing. Available at: file:///C:/Users/19.12.93/Desktop/tub_Global%20TB%20full_report%202009.pdf. Accessed 20 July 2016. 3. World Health Organisation (WHO). 2010/2011 Tuberculosis Global Facts. 2010 Nov. Available at: http://www.who.int/tb/publications/2010/factsheet_tb_2010.pdf. Accessed 20 July 2016. 4. World Health Organisation (WHO). Global Tuberculosis Report 2015. 20th ed. Available at: http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf. Accessed 20 July 2016. 5. Nasehi M, Mirhaghani L. [Country guide TB]. 2nd ed. Tehran: Andishmand Publication. 2010; pp: 30-33. [Persian] 6. Ahmed N, Hasnain SE. Molecular epidemiology of tuberculosis in India: moving forward with a systems biology approach. Tuberculosis (Edinb). 2011 Sep; 91(5): 407-13. doi:10.1016/j.tube.2011.03.006 7. Wang JY, Lee LN, Yu CJ, Chien YJ, Yang PC; Tami Group. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis. Respirology. 2009 Sep; 14(7): 1012-19. doi:10.1111/j.1440-1843.2009.01598.x 8. Mitchison DA. Clinical development of anti-tuberculosis drugs. J Antimicrob Chemother. 2006 Sep; 58(3): 494-95. doi:10.1093/jac/dkl260 9. Ukwaja KN, Oshi DC, Oshi SN, Alobu I. Profile and treatment outcome of smear-positive TB patients who failed to smear convert after 2 months of treatment in Nigeria. Trans R Soc Trop Med Hyg. 2014 Jul; 108(7): 431-38. doi:10.1093/trstmh/tru070 10. Pajankar S, Khandekar R, Amer Al Amri M, Redha Al Lawati M. Factors influencing sputum smear conversion at one and two months of tuberculosis treatmen. Oman Med J. 2008 Oct; 23(4): 263-68. 11. Güler M, Unsal E, Dursun B, Aydln O, Capan N. Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis. Int J Clin Pract. 2007 Feb; 61(2): 231-35. doi:10.1111/j.1742-1241.2006.01131.x 12. Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, Lönnroth K, Ottmani SE, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011 Jul; 9: 81. doi:10.1186/1741-7015-9-81 13. Chang JT, Dou HY, Yen CL, Wu YH, Huang RM, Lin HJ, et al. Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: a potential role in the emergence of multidrug-resistance. J Formos Med Assoc. 2011 Jun; 110(6): 372-81. doi:10.1016/S0929-6646(11)60055-7 14. Ferrara G, Murray M, Winthrop K, Centis R, Sotgiu G, Migliori GB, et al. Risk factors associated with pulmonary tuberculosis: smoking, diabetes and anti-TNF drugs. Curr Opin Pulm Med. 2012 May; 18(3): 233-40. doi:10.1097/MCP.0b013e328351f9d6 15. Palacios E, Dallman R, Muñoz M, Hurtado R, Chalco K, Guerra D, et al. Drug-resistant tuberculosis and pregnancy: treatment outcomes of 38 cases in Lima, Peru. Clin Infect Dis. 2009 May; 48(10): 1413-19. doi:10.1086/598191 16. Bernabe-Ortiz A, Carcamo CP, Sanchez JF, Rios J. Weight variation over time and its association with tuberculosis treatment outcome: a longitudinal analysis. PLoS One. 2011 Apr; 6(4): e18474. doi:10.1371/journal.pone.0018474 17. Parwati I, van Crevel R, van Soolingen D. Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect Dis. 2010 Feb; 10(2): 103-11. doi:10.1016/S1473-3099(09)70330-5 18. Metanat M, Sharifi-Mood B, Parsi M, Sanei-Moghaddam S. [Effect of cigarette smoking on sputum smear conversion time among adult new pulmonary tuberculosis patients: A study from Iran Southeast Iranian]. Iranian Journal of Clinical Infectious Diseases. 2010; 5(1): 14-17. [Article in Persian] 19. Moosazadeh M, Nasehi MM, Amiresmaili M R, Nezammahalleh A. [Efficiency of directly observed treatment short-course (DOTS) strategy in treating patients with smear positive pulmonary tuberculosis]. J Zabol Uni Med Sci Health Service. 2013; 4(4): 47-56. [Article in Persian] 20. World Healh Organization (WHO). International Standard for tuberculosis care. 3rd ed. 2014. Available at: http://www.who.int/tb/publications/ISTC_3rdEd.pdf. Accessed 3 July 2016 21. Arab Borzou Z, Afzal Aghaei M, Esmaeli H, Samiei A, Jamali J, Mohammadzade Lari Sh. [Evaluating related factors with sputum smear negation at the end of the second month of tuberculosis treatment]. Med J Mashad Univ Med Sci. 2016; 58(10): 547-54. [Article in Persian] 22. Banu Rekha VV, Balasubramanian R, Swaminathan S, Ramachandran R, Rahman F, Sundaram V, et al. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors. Indian J Med Res. 2007 Nov; 126(5): 452-58. 23. Caetano Mota P, Carvalho A, Valente I, Braga R, Duarte R. Predictors of delayed sputum smear and culture conversion among a Portuguese population with pulmonary tuberculosis. Rev Port Pneumol. 2012 Mar-Apr; 18(2): 72-79. doi:10.1016/j.rppneu.2011.12.005 [Article in English, Portuguese] 24. Gopi PG, Chandrasekaran V, Subramani R, Santha T, Thomas A, Selvakumar N, et al. Association of conversion & cure with initial smear grading among new smear positive pulmonary tuberculosis patients treated with Category I regimen. Indian J Med Res. 2006 Jun; 123(6): 807-14. 25. Garrido Mda S, Penna ML, Perez-Porcuna TM, de Souza AB, Marreiro Lda S, Albuquerque BC, et al. Factors associated with tuberculosis treatment default in an endemic area of the Brazilian Amazon: a case control-study. PLoS One. 2012; 7(6): e39134. doi:10.1371/journal.pone.0039134 26. Kuaban C, Bame R, Mouangue L, Djella S, Yomgni C. Non conversion of sputum smears in new smear positive pulmonary tuberculosis patients in Yaoundé, Cameroon. East Afr Med J. 2009 May; 86(5): 219-25. 27. Singla R, Khan N, Al-Sharif N, Ai-Sayegh MO, Shaikh MA, Osman MM. Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients. Int J Tuberc Lung Dis. 2006 Jan; 10(1): 74-79. 28. Khazaei S, Kousehlou Z, Karami M, Zahiri A, Bathaei J. [Time to sputum conversion among patients with smear-positive pulmonary tuberculosis and its determinants: A retrospective cohort study in Hamadan province, Iran]. Iran J Epidemiol. 2012; 9(1): 32-40. [Article in Persian] 29. Behnaz F, Mohammadzadeh M, Mohammadzade G. Five-year assessment of time of sputum smears conversion and outcome and risk factors of tuberculosis patients in central Iran. Tuberc Res Treat. 2015; Article ID: 609083. http://dx.doi.org/10.1155/2015/609083 30. Farazi A, Jabari Asl M, Sofiyan M. [Effect of smear positive pulmonary tuberculosis patients on treatment response]. J Med Counc I.R. Iran. 2011; 29(2): 150-56. [Article in Persian] 31. Bouti Kh, Aharmim M, Marc K, Soualhi M, Zahraoui R, Benamor J, et al. Factors influencing sputum conversion among smear-positive pulmonary tuberculosis patients in Morocco. ISRN Pulmonology. 2013; Article ID: 486507. http://dx.doi.org/10.1155/2013/486507 32. Lee HY, Chae KO, Lee CH, Choi SM, Lee J, Park YS, et al. Culture conversion rate at 2 months of treatment according to diagnostic methods among patients with culture-positive pulmonary tuberculosi. PLoS One. 2014; 9(8): e103768. doi:10.1371/journal.pone.0103768 33. Fortún J, Martín-Dávila P, Molina A, Navas E, Hermida JM, Cobo J, et al. Sputum conversion among patients with pulmonary tuberculosis: are there implications for removal of respiratory isolation? J Antimicrob Chemother. 2007 Apr; 59(4): 794-98. 34. Faurholt-Jepsen D, Range N, Praygod G, Jeremiah K, Faurholt-Jepsen M, Aabye MG, et al. Diabetes is a risk factor for pulmonary tuberculosis: a case-control study from Mwanza, Tanzania. PLoS One. 2011; 6(8): e24215. doi:10.1371/journal.pone.0024215 35. Wang CS, Yang CJ, Chen HC, Chuang SH, Chong IW, Hwang JJ, et al. Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis. Epidemiol Infect. 2009 Feb; 137(2): 203-10. doi:10.1017/S0950268808000782 36. Prasad P, Gounder S, Varman S, Viney K. Sputum smear conversion and treatment outcomes for tuberculosis patients with and without diabetes in Fiji. Public Health Action. 2014 Sep; 4(3): 159–63. doi:10.5588/pha.14.0023 37. Yaghini N, Mahmoodi M, Asadikaram GhR, Hassanshahi GhH, Khoramdelazad H, Arababadi MK. [Serum levels of interleukin10 (IL-10) in patients with type 2 diabetes]. Iran Red Crescent Med J. 2011 Oct; 13(10): 752.
|
